Magazine

Last edition
november-december 2024

Home › Business ›Statkraft and AstraZeneca Ink Agreement to Deliver Wind Power in Sweden

Statkraft and AstraZeneca Ink Agreement to Deliver Wind Power in Sweden

Under the agreement, AstraZeneca commits to purchasing 200 gigawatt-hours per year for ten years, equivalent to two terawatt-hours.

August 09, 2023. By EI News Network

Statkraft and AstraZeneca have entered into an agreement on wind power deliveries that will rise the supply of renewable electricity in Sweden. The agreement is based on the commissioning of new wind farms.

Under the agreement, AstraZeneca commits to purchasing 200 gigawatt-hours per year for ten years, equivalent to two terawatt-hours. This corresponds to approximately 80 percent of the company's total electricity needs at its research facility in Gothenburg and manufacturing facility in Södertälje.

AstraZeneca in Sweden has been using 100 percent certified renewable energy for several years. Through the agreement with Statkraft, the company will also be able to increase access to renewable energy in the community where it operates. The three wind farms are in Strömstad and Årjäng, which is in Sweden’s bidding area 3 (SE3), where AstraZeneca's research and manufacturing facilities are also situated. The wind farms are owned by Rabbalshede Kraft, who will also be responsible for their operation.

Per Alfredsson, President AstraZeneca AB, Sweden stated, “We want to contribute to the green transition in society. It is important for us to support initiatives that increase the availability of renewable energy. To successfully mitigate climate change, we must collaborate across different sectors and think beyond our own operations. Here we see an opportunity to contribute to the increase of renewable energy in society.”

Hallvard Granheim, Executive Vice President of Markets at Statkraft, added, “We are very pleased to support this ambitious initiative for a sustainable transition. This agreement confirms the role of Statkraft as a leading supplier of renewable energy to Nordic industries and our ambition to be a leading market integrator in the energy system.”

Statkraft is Europe’s largest renewable energy producer, developing, building and operating hydro, wind, solar, gas and biomass assets.

AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology firm based at the Cambridge Biomedical Campus in Cambridge, England.

Tags:

Renewable energy sector

Nordic industries

Wind farm development